Erste Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.2M | Buy |
869,213
+177,564
| +26% | +$4.64M | 0.16% | 145 |
|
|
2026
Q1 | $19.2M | Buy |
691,649
+27,830
| +4% | +$741K | 0.18% | 129 |
|
|
2025
Q4 | $16.6M | Buy |
663,819
+498,898
| +303% | +$12.6M | 0.14% | 149 |
|
|
2025
Q3 | $3.94M | Sell |
164,921
-102,213
| -38% | -$2.52M | 0.04% | 280 |
|
|
2025
Q2 | $6.46M | Buy |
267,134
+20,420
| +8% | +$476K | 0.05% | 246 |
|
|
2025
Q1 | $6.22M | Sell |
246,714
-185,585
| -43% | -$4.86M | 0.08% | 205 |
|
|
2024
Q4 | $11.5M | Sell |
432,299
-144,444
| -25% | -$3.92M | 0.14% | 146 |
|
|
2024
Q3 | $16.8M | Buy |
576,743
+89,332
| +18% | +$2.61M | 0.2% | 125 |
|
|
2024
Q2 | $13.6M | Buy |
487,411
+15,204
| +3% | +$419K | 0.18% | 129 |
|
|
2024
Q1 | $13.1M | Sell |
472,207
-37,032
| -7% | -$1.03M | 0.18% | 132 |
|
|
2023
Q4 | $14.7M | Buy |
509,239
+106,929
| +27% | +$3.23M | 0.21% | 120 |
|
|
2023
Q3 | $13M | Sell |
402,310
-837,036
| -68% | -$29.6M | 0.22% | 116 |
|
|
2023
Q2 | $45.1M | Buy |
1,239,346
+72,850
| +6% | +$2.84M | 0.79% | 33 |
|
|
2023
Q1 | $47.3M | Sell |
1,166,496
-101,428
| -8% | -$4.38M | 0.91% | 20 |
|
|
2022
Q4 | $65M | Buy |
1,267,924
+42,342
| +3% | +$2.03M | 1.37% | 7 |
|
|
2022
Q3 | $54M | Buy |
1,225,582
+45,501
| +4% | +$2.21M | 1.21% | 10 |
|
|
2022
Q2 | $60.6M | Buy |
1,180,081
+285,369
| +32% | +$14.5M | 1.35% | 6 |
|
|
2022
Q1 | $46.8M | Buy |
894,712
+511,119
| +133% | +$26.5M | 0.89% | 26 |
|
|
2021
Q4 | $22.1M | Buy |
383,593
+196,186
| +105% | +$9.72M | 0.4% | 74 |
|
|
2021
Q3 | $8.15M | Buy |
187,407
+919
| +0.5% | +$40.7K | 0.16% | 152 |
|
|
2021
Q2 | $7.29M | Buy |
186,488
+176,405
| +1,750% | +$6.86M | 0.15% | 161 |
|
|
2021
Q1 | $364K | Sell |
10,083
-1,000
| -9% | -$35.5K | 0.01% | 412 |
|
|
2020
Q4 | $409K | Sell |
11,083
-101,441
| -90% | -$3.72M | 0.01% | 406 |
|
|
2020
Q3 | $3.86M | Sell |
112,524
-7,548
| -6% | -$265K | 0.13% | 175 |
|
|
2020
Q2 | $3.72M | Buy |
120,072
+39,905
| +50% | +$1.36M | 0.15% | 156 |
|
|
2020
Q1 | $2.48M | Sell |
80,167
-43,910
| -35% | -$1.5M | 0.14% | 168 |
|
|
2019
Q4 | $4.63M | Buy |
124,077
+8,959
| +8% | +$319K | 0.2% | 120 |
|
|
2019
Q3 | $3.95M | Sell |
115,118
-2,108
| -2% | -$76.7K | 0.21% | 122 |
|
|
2019
Q2 | $4.83M | Sell |
117,226
-32,073
| -21% | -$1.27M | 0.26% | 103 |
|
|
2019
Q1 | $5.99M | Buy |
149,299
+32,916
| +28% | +$1.32M | 0.34% | 77 |
|
|
2018
Q4 | $4.73M | Buy |
+116,383
| New | +$4.83M | 0.32% | 77 |
|
Other funds holding PFE
Erste Asset Management's PFE Position: Q2 2026 in Review
Erste Asset Management increased its Pfizer (PFE) stake by 26% in Q2 2026, buying an estimated $4.64M and bringing the position to 869,213 shares worth $21.2M. The position accounts for 0.16% of the portfolio, ranked #145.
Erste Asset Management first reported a position in PFE in Q4 2018 and has held it in 31 quarters since. The position peaked at $65M in Q4 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Erste Asset Management held 869,213 shares of Pfizer worth $21.2M as of Q2 2026.
- Erste Asset Management bought 177,564 Pfizer shares in Q2 2026, an estimated $4.64M.
- Pfizer made up 0.16% of Erste Asset Management's portfolio in Q2 2026, its #145 holding.
- Erste Asset Management first reported a position in Pfizer in Q4 2018 and has held it in 31 quarters since.
- Erste Asset Management's Pfizer position peaked at $65M in Q4 2022.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.